Suicidal erythrocyte death triggered by cisplatin

Toxicology

Volumn 249, Issue 1, 2008, Pages 40-44

  Mahmud, Hasan ^a   Föller, Michael ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Annexin; Calcium; Cell volume; Eryptosis; Phosphatidylserine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CERAMIDE; CISPLATIN; LIPOCORTIN 5;

ANEMIA; ARTICLE; CELL DEATH; CELL VOLUME; ERYTHROCYTE; EXTRACELLULAR CALCIUM; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; HEMOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATASES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM; CELL SIZE; CERAMIDES; CISPLATIN; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLOW CYTOMETRY; HEMOLYSIS; HUMANS; PHOSPHATIDYLSERINES;

EID: 44649114537     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.04.003     Document Type: Article

References (56)

1. Akel A., Hermle T., Niemoeller O.M., Kempe D.S., Lang P.A., Attanasio P., Podolski M., Wieder T., and Lang F. Stimulation of erythrocyte phosphatidylserine exposure by chlorpromazine. Eur. J. Pharmacol. 532 (2006) 11-17
2. Alfieri A.B., and Cubeddu L.X. Role of NK1 receptors on cisplatin-induced nephrotoxicity in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 361 (2000) 334-338
3. Badary O.A., Abdel-Naim A.B., Khalifa A.E., and Hamada F.M. Differential alteration of cisplatin cytotoxicity and myelotoxicity by the paclitaxel vehicle cremophor EL. Naunyn Schmiedebergs Arch. Pharmacol. 361 (2000) 339-344
4. Badary O.A., Sharaby S.M., Kenawy S.A., El Denshary E.E., and Hamada F.M. Evaluation of cisplatin combined with ondansetron in Ehrlich ascites carcinoma in vitro and in vivo. Tumori 86 (2000) 153-156
5. Bentzen P.J., Lang E., and Lang F. Curcumin induced suicidal erythrocyte death. Cell Physiol. Biochem. 19 (2007) 153-164
6. Berg C.P., Engels I.H., Rothbart A., Lauber K., Renz A., Schlosser S.F., Schulze-Osthoff K., and Wesselborg S. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ. 8 (2001) 1197-1206
7. Boas F.E., Forman L., and Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3077-3081
8. Bookchin R.M., Ortiz O.E., and Lew V.L. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog. Clin. Biol. Res. 240 (1987) 193-200
9. Brand V.B., Sandu C.D., Duranton C., Tanneur V., Lang K.S., Huber S.M., and Lang F. Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol. Biochem. 13 (2003) 347-356
10. Bratosin D., Estaquier J., Petit F., Arnoult D., Quatannens B., Tissier J.P., Slomianny C., Sartiaux C., Alonso C., Huart J.J., Montreuil J., and Ameisen J.C. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ. 8 (2001) 1143-1156
11. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 92 (1993) 520-526
12. Canpolat C., Pearson P., and Jaffe N. Cisplatin-associated hemolytic uremic syndrome. Cancer 74 (1994) 3059-3062
13. Chirino Y.I., Sanchez-Gonzalez D.J., Martinez-Martinez C.M., Cruz C., and Pedraza-Chaverri J. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 245 (2008) 18-23
14. Daugas E., Cande C., and Kroemer G. Erythrocytes: death of a mummy. Cell Death Differ. 8 (2001) 1131-1133
15. Deegan P.M., Basinger M.A., Jones M.M., and Hande K.R. Prevention of cisplatin nephrotoxicity by exogenous atrial natriuretic peptide. Toxicology 106 (1996) 159-166
16. 2+-induced scrambling of various fluorescently labelled lipid analogues in red blood cells. Biochem. J. 362 (2002) 741-747
17. Duranton C., Huber S.M., and Lang F. Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J. Physiol. 539 (2002) 847-855
18. Duranton C., Huber S., Tanneur V., Lang K., Brand V., Sandu C., and Lang F. Electrophysiological properties of the Plasmodium falciparum-induced cation conductance of human erythrocytes. Cell Physiol. Biochem. 13 (2003) 189-198
19. Eisele K., Lang P.A., Kempe D.S., Klarl B.A., Niemoller O., Wieder T., Huber S.M., Duranton C., and Lang F. Stimulation of erythrocyte phosphatidylserine exposure by mercury ions. Toxicol. Appl. Pharmacol. (2005)
20. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., and Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405 (2000) 85-90
21. Foller M., Shumilina E., Lam R., Mohamed W., Kasinathan R., Huber S., Chakraborty T., and Lang F. Induction of suicidal erythrocyte death by listeriolysin from Listeria monocytogenes. Cell Physiol. Biochem. 20 (2007) 1051-1060
22. Föller, M., Geiger, C., Mahmud, H., Nicolay, J.P., Lang, F., 2008. Stimulation of suicidal erythrocyte death by amantadine. Eur. J. Pharmacol. 581, 13-18.
23. Francescato H.D., Costa R.S., Junior F.B., and Coimbra T.M. Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol. Dial. Transplant. 22 (2007) 2138-2148
24. Glynne-Jones R., and Hoskin P. Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?. J. Clin. Oncol. 25 (2007) 5281-5286
25. Havelka A.M., Berndtsson M., Olofsson M.H., Shoshan M.C., and Linder S. Mechanisms of action of DNA-damaging anticancer drugs in treatment of carcinomas: is acute apoptosis an "off-target" effect?. Mini Rev. Med. Chem. 7 (2007) 1035-1039
26. Huber S.M., Gamper N., and Lang F. Chloride conductance and volume-regulatory nonselective cation conductance in human red blood cell ghosts. Pflugers Arch. 441 (2001) 551-558
27. Iseri S., Ercan F., Gedik N., Yuksel M., and Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 230 (2007) 256-264
28. Kempe D.S., Lang P.A., Eisele K., Klarl B.A., Wieder T., Huber S.M., Duranton C., and Lang F. Stimulation of erythrocyte phosphatidylserine exposure by lead ions. Am. J. Physiol. Cell Physiol. 288 (2005) C396-C402
29. Kempe D.S., Lang P.A., Duranton C., Akel A., Lang K.S., Huber S.M., Wieder T., and Lang F. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J. 20 (2006) 368-370
30. Klarl B.A., Lang P.A., Kempe D.S., Niemoeller O.M., Akel A., Sobiesiak M., Eisele K., Podolski M., Huber S.M., Wieder T., and Lang F. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am. J. Physiol. Cell Physiol. 290 (2006) C244-C253
31. Lang K.S., Duranton C., Poehlmann H., Myssina S., Bauer C., Lang F., Wieder T., and Huber S.M. Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ. 10 (2003) 249-256
32. + channels in human erythrocyte apoptosis. Am. J. Physiol. Cell Physiol. 285 (2003) C1553-C1560
33. Lang P.A., Warskulat U., Heller-Stilb B., Huang D.Y., Grenz A., Myssina S., Duszenko M., Lang F., Haussinger D., Vallon V., and Wieder T. Blunted apoptosis of erythrocytes from taurine transporter deficient mice. Cell Physiol. Biochem. 13 (2003) 337-346
34. Lang K.S., Myssina S., Brand V., Sandu C., Lang P.A., Berchtold S., Huber S.M., Lang F., and Wieder T. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ. 11 (2004) 231-243
35. Lang P.A., Kaiser S., Myssina S., Birka C., Weinstock C., Northoff H., Wieder T., Lang F., and Huber S.M. Effect of Vibrio parahaemolyticus haemolysin on human erythrocytes. Cell Microbiol. 6 (2004) 391-400
36. Lang P.A., Beringer O., Nicolay J.P., Amon O., Kempe D.S., Hermle T., Attanasio P., Akel A., Schafer R., Friedrich B., Risler T., Baur M., Olbricht C.J., Zimmerhackl L.B., Zipfel P.F., Wieder T., and Lang F. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J. Mol. Med. 84 (2006) 378-388
37. Lang P.A., Huober J., Bachmann C., Kempe D.S., Sobiesiak M., Akel A., Niemoeller O.M., Dreischer P., Eisele K., Klarl B.A., Gulbins E., Lang F., and Wieder T. Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. Cell Physiol. Biochem. 18 (2006) 151-164
38. Lang P.A., Schenck M., Nicolay J.P., Becker J.U., Kempe D.S., Lupescu A., Koka S., Eisele K., Klarl B.A., Rubben H., Schmid K.W., Mann K., Hildenbrand S., Hefter H., Huber S.M., Wieder T., Erhardt A., Haussinger D., Gulbins E., and Lang F. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 13 (2007) 164-170
39. Lock E.A., Reed C.J., Kinsey G.R., and Schnellmann R.G. Caspase-dependent and -independent induction of phosphatidylserine externalization during apoptosis in human renal carcinoma Cak(1)-1 and A-498 cells. Toxicology 229 (2007) 79-90
40. Naziroglu M., Karaoglu A., and Aksoy A.O. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195 (2004) 221-230
41. Nicolay J.P., Schneider J., Niemoeller O.M., Artunc F., Portero-Otin M., Haik Jr. G., Thornalley P.J., Schleicher E., Wieder T., and Lang F. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol. Biochem. 18 (2006) 223-232
42. Nicolay J.P., Gatz S., Liebig G., Gulbins E., and Lang F. Amyloid induced suicidal erythrocyte death. Cell Physiol. Biochem. 19 (2007) 175-184
43. Niemoeller O.M., Akel A., Lang P.A., Attanasio P., Kempe D.S., Hermle T., Sobiesiak M., Wieder T., and Lang F. Induction of eryptosis by cyclosporine. Naunyn Schmiedebergs Arch. Pharmacol. 374 (2006) 41-49
44. Niemoeller O.M., Kiedaisch V., Dreischer P., Wieder T., and Lang F. Stimulation of eryptosis by aluminium ions. Toxicol. Appl. Pharmacol. 217 (2006) 168-175
45. Saif M.W., and Kim R. Role of platinum agents in the management of advanced pancreatic cancer. Expert Opin. Pharmacother. 8 (2007) 2719-2727
46. Sato S., Yamate J., Saito T., Hosokawa T., Saito S., and Kurasaki M. Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. Naunyn Schmiedebergs Arch. Pharmacol. 365 (2002) 277-283
47. Schneider J., Nicolay J.P., Foller M., Wieder T., and Lang F. Suicidal erythrocyte death following cellular K+ loss. Cell Physiol. Biochem. 20 (2007) 35-44
48. Scott R.H., Woods A.J., Lacey M.J., Fernando D., Crawford J.H., and Andrews P.L. An electrophysiological investigation of the effects of cisplatin and the protective actions of dexamethasone on cultured dorsal root ganglion neurones from neonatal rats. Naunyn Schmiedebergs Arch. Pharmacol. 352 (1995) 247-255
49. Shumilina E., Kiedaisch V., Akkel A., Lang P., Hermle T., Kempe D.S., Huber S.M., Wieder T., Laufer S., and Lang F. Stimulation of suicidal erythrocyte death by lipoxygenase inhibitor Bay-Y5884. Cell Physiol. Biochem. 18 (2006) 233-242
50. Sopjani, M., Föller, M., Lang, F., 2008. Gold stimulates Ca(2+) entry into and subsequent suicidal death of erythrocytes. Toxicology. 244, 271-279.
51. Stewart D.J., Benjamin R.S., Zimmerman S., Caprioli R.M., Wallace S., Chuang V., Calvo III D., Samuels M., Bonura J., and Loo T.L. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). Cancer Res. 43 (1983) 917-920
52. Stewart D.J., Feun L.G., Maor M., Leavens M., Burgess M.A., Benjamin R.S., and Bodey Sr. G.P. Weekly Cisplatin during cranial irradiation for malignant melanoma metastatic to brain. J. Neurooncol. 1 (1983) 49-51
53. Stewart D.J., O'Bryan R.M., Al Sarraf M., Costanzi J.J., and Oishi N. Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study. J. Neurooncol. 1 (1983) 145-147
54. Vandendries E.R., and Drews R.E. Drug-associated disease: hematologic dysfunction. Crit. Care Clin. 22 (2006) 347-355 viii
55. Vermorken J.B., van der Vijgh W.J., Klein I., Hart A.A., Gall H.E., and Pinedo H.M. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat. Rep. 68 (1984) 505-513
56. 2+ sensitivity of phospholipid scrambling in human red cell ghosts. Cell Calcium 25 (1999) 313-320